Across TCGA pan-cancer cohorts, RNU6-1094P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-1094P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RNU6-1094P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1094P expression acts as an unfavorable survival marker.

THCA, OV, and LIHC are the cancer types where RNU6-1094P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.521	0.950	<.001	90	view →
OV	OS	Tertile	III,IV	0.384	0.686	.003	54	view →
LIHC	DFS	Tertile	All	0.077	0.527	.002	45	view →
ESCA	DFS	Tertile	All	0.052	0.533	<.001	36	view →
UCEC	OS	Tertile	All	0.137	0.678	.040	36	view →
SARC	OS	Tertile	All	0.126	0.860	<.001	36	view →
BRCA	DFS	Tertile	II,III,IV	0.622	0.890	.028	24	view →
TGCT	DFS	Tertile	All	0.059	0.802	<.001	18	view →
STAD	DFS	Tertile	All	0.395	0.636	.016	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

Exploration

Same gene, other analysis: RNU6-1094P tumor-vs-normal RNA expression · all RNU6-1094P data types